Home › Mining › Viridis Mining and Minerals (ASX:VMM)

Viridis wins fresh Brazilian backing for Colossus at premium price

Mining By Maxwell Dee 4 min read

Viridis Mining and Minerals has received the second US$5 million tranche under its Brazilian funding agreement, with the shares issued at a 17% premium to the last close. The investment strengthens Colossus’ equity funding position, but senior debt, permitting and final project approval remain ahead.

  • US$5 million second tranche received under unchanged US$30 million agreement
  • 2,080,125 shares issued at A$3.40 each, a 17% premium to the last close
  • Brazilian Critical Minerals Fund backed by Vale and BNDESPAR is funding the tranche
  • Approximately US$141 million in pro forma cash and equity funding claimed against a US$133 million indicative equity requirement
  • Remaining milestones include US$20 million of funding, senior debt and permitting

Brazilian fund delivers second US$5 million tranche

Viridis Mining and Minerals Limited (ASX:VMM) has received a second US$5 million tranche for its Colossus rare earths project in Brazil, with the funding arriving through a critical minerals vehicle backed by Vale and BNDESPAR. The shares were issued at A$3.40 each, a 17% premium to Viridis’ previous closing price, giving the transaction a more constructive market signal than a discounted equity raise.

The issue comprised 2,080,125 new shares under the existing US$30 million binding agreement with ORE Investments and Régia Capital. That agreement has not changed: the initial US$5 million was funded in November 2025, today’s tranche is the second, and a further US$20 million remains to be invested through the fund, subject to applicable conditions.

Vale and BNDESPAR deepen Colossus backing

Viridis is the inaugural investment of the ORE Régia FIP Critical Minerals Fund, which was established with Vale and BNDESPAR as cornerstone investors. Each has committed R$250 million, alongside about R$500 million from other domestic and international investors, creating an investment platform of approximately R$1 billion for strategic minerals projects in Brazil.

The institutional support matters because Colossus is being positioned not simply as a mining project, but as part of Brazil’s emerging domestic rare earth supply chain. The company has also secured a binding Solvay offtake covering most of forecast output, with minimum contractual volumes previously reported to underpin about US$915 million in revenue at agreed price floors. Viridis says the fund’s strategy aligns with its plans to introduce rare earth separation capabilities in Brazil.

Equity position approaches stated development requirement

“The indicative equity component reflects 30% of the US$449 million Definitive Feasibility Study (‘DFS’) development capital requirement.”Caption and image © Viridis Mining and Minerals Limited. From “2nd US$5M from Brazilian Critical Minerals Fund & Cleansing”, 16 Nov 2026.

Viridis says it now has approximately US$141 million in pro forma cash and equity funding against an indicative remaining equity requirement of about US$133 million. The company’s target funding mix is approximately 70% senior debt and 30% equity against the US$449 million development capital requirement outlined in its definitive feasibility study.

That headline position needs to be read with the qualifications attached. The pro forma figure includes investment proceeds subject to applicable conditions and completion, while a second tranche from One Investment Management remains subject to Foreign Investment Review Board review and approval. Viridis expects that tranche by the end of the December quarter.

Senior debt and permitting remain the decisive tests

Managing Director Rafael Moreno said the company’s focus was now on finalising senior debt financing and permitting while engineering and procurement continued towards targeted production in 2028. The company has already begun moving Colossus towards execution, including early engineering and procurement work, while a previously approved BNDES financing facility was reported to support Brazilian processing and research infrastructure.

The new tranche reduces uncertainty around the equity side of the project’s proposed capital structure, but it does not remove the larger execution hurdles. Viridis still needs to complete the remaining funding under the ORE and Régia agreement, secure senior debt, obtain the required permits and reach a final investment decision. The 2028 production target therefore remains a company objective rather than an achieved project milestone.

Bottom Line?

The equity leg is becoming more tangible, but Colossus still depends on debt financing, approvals and completion of conditional funding before construction risk materially recedes.

Questions in the middle?

  • Will the remaining US$20 million under the ORE and Régia agreement arrive on the stated timetable and without new conditions?
  • When will Viridis complete senior debt financing and reach a final investment decision for Colossus?
  • Can permitting, engineering and procurement progress quickly enough to preserve the targeted 2028 production schedule?

Sources